Research Funding
- Acute to Chronic Pain Signatures (A2CPS)
- Extracellular RNA Communication
- Gabriella Miller Kids First
- Glycoscience
- NIH Director's Early Independence Award
- NIH Director's New Innovator Award
- NIH Director's Pioneer Award
- NIH Director's Transformative Research Award
- Illuminating the Druggable Genome
- Somatic Cell Genome Editing
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
Acute to Chronic Pain Signatures (A2CPS)
Extracellular RNA Communication
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 8/6/2018 | RFA-RM-18-026 | John Satterlee satterleej@nida.nih.gov 301-435-1020 |
Letter of Intent: 9/23/2018 Receipt Date: 10/23/2018 |
|
| Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed) | 8/6/2018 | RFA-RM-18-027 | Kevin Howcroft Howcrofk@mail.nih.gov 240-276-6229 |
Letter of Intent: 9/23/2018 Receipt Date: 10/23/2018 |
| Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed) | 8/6/2018 | RFA-RM-18-028 | Danilo A. Tagle Danilo.Tagle@nih.gov 301-594-8064 |
Letter of Intent: 9/23/2018 Receipt Date: 10/23/2018 |
Gabriella Miller Kids First
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 7/23/2018 | RFA-RM-18-030 | James Coulombe CoulombeJ@mail.nih.gov 301-451-1390 |
Letter of Intent: 9/30/2018 Receipt Date: 10/31/2018 |
Glycoscience
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 8/10/2018 | RFA-RM-18-036 | Karl E. Krueger kruegerk@mail.nih.gov 240-276-7026 |
Letter of Intent: 30 days before receipt date Receipt date: 10/29/18 |
|
| Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed) | 8/10/2018 | RFA-RM-18-037 | Karl E. Krueger kruegerk@mail.nih.gov 240-276-7026 |
Letter of Intent: 30 days before receipt date Receipt date: 10/29/18 |
High-Risk Research: NIH Director's Early Independence Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 3/26/2018 | RFA-RM-18-010 | Ravi Basavappa earlyindependence@mail.nih.gov (301) 435-7204 |
Letter of Intent: 8/27/2018 Receipt Date: 9/27/2018 |
|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 8/22/2018 | PA-18-906 | Ravi Basavappa earlyindependence@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa earlyindependence@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's New Innovator Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 8/22/2018 | PA-18-906 | Ravi Basavappa NewInnovatorAward@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa NewInnovatorAward@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Pioneer Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2019 NIH Director's Pioneer Award Program (DP1 Clinical Trial Optional) | 4/23/2018 | RFA-RM-18-007 | Dr. Ravi Basavappa PioneerAwards@mail.nih.gov 301 435-7204 |
9/14/2018 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 8/22/2018 | PA-18-906 | Ravi Basavappa PioneerAwards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa PioneerAwards@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Transformative Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 8/22/2018 | PA-18-906 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
Illuminating the Druggable Genome
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) | 7/20/2018 | RFA-RM-18-021 | Christine Colvis DruggableGenome@mail.nih.gov 301-451-3903 |
Letter of Intent: 9/26/2018 Receipt Date: 10/26/2018 |
Somatic Cell Genome Editing
Stimulating Peripheral Activity to Relieve Conditions (SPARC)
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| SPARC Partnership Opportunity: Custom Arrangements for Device-Based Clinical Studies with Flexible Data and Intellectual Property Rights Notice of Intent to Publish a Funding Opportunity Announcement for SPARC Clinical Studies of Peripheral and Spinal Neuromodulation Devices to Support New Indications and Human Functional Mapping (OT2 Clinical Trial Required) |
6/29/2018 | OTA-18-019 | SPARC3 Program Team SPARC_TPNI@mail.nih.gov |
Mandatory Letter of Intent: 9/7/2018 Proposal: 10/15/2018 |
Past Funding Opportunities
• 4D Nucleome
• Big Data to Knowledge
• Bioinformatics and Computational Biology
• Bridging Interventional Development Gaps (BrIDGs)
• Building Blocks, Biological Pathways and Networks
• Enhancing the Diversity of the NIH-Funded Workforce
• Epigenomics
• Extracellular RNA Communication
• Genotype-Tissue Expression (GTEx)
• Global Health
• Glycoscience
• Gulf Oil Spill
• HCS Research Collaboratory
• Health Economics
• High-Risk Research:
• NIH Director’s Early Independence Award (EIA)
• NIH Director’s New Innovator Award
• NIH Director’s Pioneer Award
• NIH Director’s Transformative Research Awards
• Human Microbiome Project
• Illuminating the Druggable Genome
• Interdisciplinary Research
• Knockout Mouse Phenotyping
• Library of Integrated Network-Based Cellular Signatures (LINCS)
• Metabolomics
• Molecular Libraries and Imaging
• Nanomedicine
• NIH Center for Regenerative Medicine (NIH CRM)
• NIH Medical Research Scholars Program
• PROMIS: Patient-Reported Outcomes Measurement Information System
• Protein Capture Reagents
• Regulatory Science
• Science of Behavior Change
• Single Cell Analysis
• Stimulating Peripheral Activity to Relieve Conditions (SPARC)
• Strengthening the Biomedical Research Workforce
• Structural Biology
• Undiagnosed Diseases
Funded Research
• 4D Nucleome
• Big Data to Knowledge
• Bioinformatics and Computational Biology
• Bridging Interventional Development Gaps (BrIDGs)
• Building Blocks, Biological Pathways and Networks
• Enhancing the Diversity of the NIH-Funded Workforce
• Epigenomics
• Extracellular RNA Communication
• Gabriella Miller Kids First
• Genotype-Tissue Expression (GTEx)
• Global Health
• Glycoscience
• HCS Research Collaboratory
• Health Economics
• High-Risk Research:
• NIH Director’s Early Independence Award (EIA)
• NIH Director’s New Innovator Award
• NIH Director’s Pioneer Award
• NIH Director’s Transformative Research Awards
• Human Microbiome Project
• Illuminating the Druggable Genome
• Interdisciplinary Research
• Knockout Mouse Phenotyping
• Library of Integrated Network-Based Cellular Signatures (LINCS)
• Metabolomics
• Molecular Libraries and Imaging
• Molecular Transducers of Physical Activity in Humans
• Nanomedicine
• NIH Center for Regenerative Medicine (NIH CRM)
• NIH Medical Research Scholars Program
• PROMIS: Patient-Reported Outcomes Measurement Information System
• ProteinCapture Reagents
• Regulatory Science
• Science of Behavior Change
• Single Cell Analysis
• Stimulating Peripheral Activity to Relieve Conditions (SPARC)
• Strengthening the Biomedical Research Workforce
• Structural Biology
• Undiagnosed Diseases
This page last reviewed on September 24, 2018